JANUVIA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Cardinal Health. The primary component is Sitagliptin Phosphate.
Product ID | 55154-5040_044fc35c-103c-4c88-83fd-936dbfa32a1c |
NDC | 55154-5040 |
Product Type | Human Prescription Drug |
Proprietary Name | JANUVIA |
Generic Name | Sitagliptin |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2006-10-16 |
Marketing Category | NDA / NDA |
Application Number | NDA021995 |
Labeler Name | Cardinal Health |
Substance Name | SITAGLIPTIN PHOSPHATE |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2006-10-16 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021995 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2006-10-16 |
Ingredient | Strength |
---|---|
SITAGLIPTIN PHOSPHATE | 50 mg/1 |
SPL SET ID: | 39253ddd-0245-43b1-ad28-d5923983afb4 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0006-0112 | JANUVIA | sitagliptin |
0006-0221 | JANUVIA | sitagliptin |
0006-0277 | JANUVIA | sitagliptin |
50090-3472 | JANUVIA | sitagliptin |
50090-3527 | JANUVIA | sitagliptin |
50090-4084 | JANUVIA | sitagliptin |
50090-4086 | JANUVIA | sitagliptin |
50090-4087 | JANUVIA | sitagliptin |
50090-5517 | JANUVIA | sitagliptin |
50090-5547 | JANUVIA | sitagliptin |
50090-5585 | JANUVIA | sitagliptin |
55154-5040 | JANUVIA | sitagliptin |
55154-5042 | JANUVIA | sitagliptin |
55154-5044 | JANUVIA | JANUVIA |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
JANUVIA 78833412 3621009 Live/Registered |
MERCK SHARP & DOHME CORP. 2006-03-09 |
JANUVIA 76635570 3261637 Live/Registered |
MERCK SHARP & DOHME CORP. 2005-04-07 |